Download SmartTRAK's Market Outlook Article
Dave Anderson, Medtronic’s President Neuromodulation, and Charlie Covert, VP and GM of Pain Therapies, discuss the Company, pandemic and the future of neuromodulation in a wide-ranging interview with SmartTRAK. To find out more about the Company’s newest innovations, expanding indications, clinical research and strategies for driving growth in SCS and DBS, read our article!
